AAAAAA

   
Results: 1-14 |
Results: 14
CONSOLIDATION WITH HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS STEM-CELL TRANSPLANT (ASCT) FOR HIGH-RISK STAGE-II-III AND STAGE-IV BREAST-CANCER PATIENTS - AN UPDATE OF 211 CONSECUTIVE PATIENTS
Authors: STEMMER SM HARDAN I RIZEL S RAZ H SAREL R GRINBERGER A ADAMOS A KITSIOS P INBAR M SHAPIRA Y BRACHA D BRENNER H
Citation: Sm. Stemmer et al., CONSOLIDATION WITH HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS STEM-CELL TRANSPLANT (ASCT) FOR HIGH-RISK STAGE-II-III AND STAGE-IV BREAST-CANCER PATIENTS - AN UPDATE OF 211 CONSECUTIVE PATIENTS, Bone marrow transplantation, 21, 1998, pp. 216-216
HIGH-DOSE MELPHALAN AND ETOPOSIDE (VP-16) WITH AUTOLOGOUS STEM-CELL SUPPORT FOR NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM) PATIENTS - A PHASE-IISTUDY
Authors: HARDAN I AVIGDOR A ATTIAS D RAZ H BERKOWICZ M RAANANI P SARELI R LEVY I BASSAT IB
Citation: I. Hardan et al., HIGH-DOSE MELPHALAN AND ETOPOSIDE (VP-16) WITH AUTOLOGOUS STEM-CELL SUPPORT FOR NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM) PATIENTS - A PHASE-IISTUDY, Bone marrow transplantation, 21, 1998, pp. 716-716
CHEMOTHERAPEUTIC PRIMING AND COLLECTION OF PHILADELPHIA NEGATIVE GRAFT FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS BY A NURSING TEAM INAN AMBULATORY SETTING
Authors: RAZ H BRACHA D SARELI R PAPATRYPHONOS A STEMMER SM HARDAN I
Citation: H. Raz et al., CHEMOTHERAPEUTIC PRIMING AND COLLECTION OF PHILADELPHIA NEGATIVE GRAFT FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS BY A NURSING TEAM INAN AMBULATORY SETTING, Bone marrow transplantation, 21, 1998, pp. 994-994
IL-2 INDUCES T-CELL ADHERENCE TO EXTRACELLULAR-MATRIX - INHIBITION OFADHERENCE AND MIGRATION BY IL-2 PEPTIDES GENERATED BY LEUKOCYTE ELASTASE
Authors: ARIEL A YAVIN EJ HERSHKOVIZ R AVRON A FRANITZA S HARDAN I CAHALON L FRIDKIN M LIDER O
Citation: A. Ariel et al., IL-2 INDUCES T-CELL ADHERENCE TO EXTRACELLULAR-MATRIX - INHIBITION OFADHERENCE AND MIGRATION BY IL-2 PEPTIDES GENERATED BY LEUKOCYTE ELASTASE, The Journal of immunology (1950), 161(5), 1998, pp. 2465-2472
SALVAGE THERAPY OF REFRACTORY ACUTE-LEUKEMIA WITH HIGH-DOSE MITOXANTRONE AND CYTARABINE
Authors: RAANANI P SHPILBERG O GILIS S AVIGDOR A HARDAN I BERKOWICZ M SOFER O LOSSOS I CHETRIT A BENYEHUDA D BENBASSAT I
Citation: P. Raanani et al., SALVAGE THERAPY OF REFRACTORY ACUTE-LEUKEMIA WITH HIGH-DOSE MITOXANTRONE AND CYTARABINE, Blood, 90(10), 1997, pp. 3842-3842
RESPIRATORY-FAILURE AND INTENSIVE-CARE TREATMENT IN BONE MARROW-TRANSPLANTED PATIENTS
Authors: ABRAHAM RB HARDAN I SEGAL E STEMMER SM PEREL A
Citation: Rb. Abraham et al., RESPIRATORY-FAILURE AND INTENSIVE-CARE TREATMENT IN BONE MARROW-TRANSPLANTED PATIENTS, Intensive care medicine, 22(3), 1996, pp. 269-270
ORAL FLUCONAZOLE RATHER THAN INTRAVENOUS AMPHOTERICIN-B (AMPH-B), AS EMPIRIC ANTIFUNGAL TREATMENT FOR NEUTROPENIC FEVER IN BREAST-CANCER PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANT
Authors: STEMMER SM HARDAN I
Citation: Sm. Stemmer et I. Hardan, ORAL FLUCONAZOLE RATHER THAN INTRAVENOUS AMPHOTERICIN-B (AMPH-B), AS EMPIRIC ANTIFUNGAL TREATMENT FOR NEUTROPENIC FEVER IN BREAST-CANCER PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANT, Blood, 88(10), 1996, pp. 3789-3789
HIGH-DOSE HYDROXYUREA AND GCSF FOR THE PREPARATION OF A PHILADELPHIA NEGATIVE (PH-) AUTOLOGOUS STEM-CELL GRAFT IN NEWLY-DIAGNOSED PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML)
Authors: HARDAN I BROKSIMONI F ROSENTHAL E TRAKHTENBROT L RAZ H SARELI R ROSNER E BERKOWICZ M BENBASSAT I
Citation: I. Hardan et al., HIGH-DOSE HYDROXYUREA AND GCSF FOR THE PREPARATION OF A PHILADELPHIA NEGATIVE (PH-) AUTOLOGOUS STEM-CELL GRAFT IN NEWLY-DIAGNOSED PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML), Blood, 88(10), 1996, pp. 1011-1011
TRANSLOCATION (2-14)(P13-Q32) IN CD10-LEUKEMIA(CD13+ACUTE LYMPHATIC)
Authors: BERKOWICZ M TOREN A ROSNER E BINIAMINOV M ROSENTHAL E GIPSH N BERMAN S HARDAN I MANDEL M AMARIGLIO N MARK Z SOFFER O RANNANI P KENET G NEUMANN Y SHARON N BROKSIMONI F RUBNOV V BENBASSAT I RECHAVI G
Citation: M. Berkowicz et al., TRANSLOCATION (2-14)(P13-Q32) IN CD10-LEUKEMIA(CD13+ACUTE LYMPHATIC), Cancer genetics and cytogenetics, 83(2), 1995, pp. 140-143
HEMATOONCOLOGY PATIENTS WITH ACUTE RESPIRATORY-FAILURE (ARF) IN THE ICU
Authors: SEGAL E BENABRAHAM R SHPILBERG O HARDAN I BENBASSAT I PEREL A
Citation: E. Segal et al., HEMATOONCOLOGY PATIENTS WITH ACUTE RESPIRATORY-FAILURE (ARF) IN THE ICU, British Journal of Anaesthesia, 74, 1995, pp. 110-110
DISSEMINATED VISCERAL FUSARIOSIS TREATED WITH AMPHOTERICIN-B-PHOSPHOLIPID COMPLEX
Authors: ENGELHARD D ELDOR A POLACHECK I HARDAN I BENYEHUDA D AMSELEM S SALKIN IF LOPEZBERESTEIN G SACKS T RACHMILEWITZ EA BARENHOLZ Y
Citation: D. Engelhard et al., DISSEMINATED VISCERAL FUSARIOSIS TREATED WITH AMPHOTERICIN-B-PHOSPHOLIPID COMPLEX, Leukemia & lymphoma, 9(4-5), 1993, pp. 385-392
GANCICLOVIR FOR THE TREATMENT OF DISSEMINATED CMV DISEASE WITHOUT PNEUMONIA IN ALLOGENEIC T-LYMPHOCYTE DEPLETED BONE-MARROW TRANSPLANTATION
Authors: ENGELHARD D NAPARSTEK E OR R NAGLER A JACOBS J BENSHAHAR M HARDAN I BACIU H RAVEH D SLAVIN S
Citation: D. Engelhard et al., GANCICLOVIR FOR THE TREATMENT OF DISSEMINATED CMV DISEASE WITHOUT PNEUMONIA IN ALLOGENEIC T-LYMPHOCYTE DEPLETED BONE-MARROW TRANSPLANTATION, Leukemia & lymphoma, 10(1-2), 1993, pp. 143-146
INHIBITION OF METASTATIC CELL COLONIZATION IN MURINE LUNGS AND TUMOR-INDUCED MORBIDITY BY NONPEPTIDIC ARG-GLY-ASP MIMETICS
Authors: HARDAN I WEISS L HERSHKOVIZ R GREENSPOON N ALON R CAHALON L REICH S SLAVIN S LIDER O
Citation: I. Hardan et al., INHIBITION OF METASTATIC CELL COLONIZATION IN MURINE LUNGS AND TUMOR-INDUCED MORBIDITY BY NONPEPTIDIC ARG-GLY-ASP MIMETICS, International journal of cancer, 55(6), 1993, pp. 1023-1028
LOW-MOLECULAR-WEIGHT HEPARIN INHIBITS PROLIFERATION AND CYTOTOXICITY OF HUMAN NATURAL-KILLER-CELLS
Authors: HARDAN I CONDIOTTI R CAHALON L LIDER O NAGLER A
Citation: I. Hardan et al., LOW-MOLECULAR-WEIGHT HEPARIN INHIBITS PROLIFERATION AND CYTOTOXICITY OF HUMAN NATURAL-KILLER-CELLS, Blood, 82(10), 1993, pp. 10000618-10000618
Risultati: 1-14 |